Investment to boost phosphate project

Avenira has secured an A$7.56 million strategic investment from majority shareholder Hebang Biotechnology to progress its Wonarah phosphate project in Northern Territory. The investment, in which Hebang will acquire 1.08 billion shares priced at A$0.007 each, will boost its equity holding in Avenira to 49%. Hebang has also agreed to provide Avenira with an unsecured drawdown loan facility to be repaid on completion of the placement or after the date of the first drawdown.